Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
Part of paid clinical trials in Neptune City, New Jersey.
- Sponsor
- AstraZeneca
- Study ID
- NCT00839683
- Phase
- PHASE1
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- simvastatin — DRUGTablets, Oral, 20 mg, Single Dose
- Dapagliflozin — DRUGTablets, Oral, 20 mg, Single Dose
- simvastatin — DRUGOral, 40 mg, Single Dose
- valsartan — DRUGTablets, Oral, 320 mg, Single Dose
Study Details
Phase A - To assess the effect of simvastatin on the pharmacokinetics (PK) of dapagliflozin and to determine the effect of dapagliflozin on the PK of simvastatin, when simvastatin and dapagliflozin are coadministered in healthy subjects. Phase B - To assess the effect of valsartan on the PK of dapagliflozin and to determine the effect of dapagliflozin on the PK of valsartan, when valsartan and dapagliflozin are coadministered in healthy subjects
Key Dates
- First listed
- Feb 9, 2009
- Start date
- Feb 28, 2009
- Status verified
- Oct 2016
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
Study Design
- Enrollment
- 24 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
Arms
- Active Comparator: simvastatin
- Active Comparator: Dapagliflozin + simvastatin
- Active Comparator: Dapagliflozin
- Active Comparator: valsartan
- Active Comparator: Dapagliflozin + valsartan
Primary Outcome Measure
Exposure to the investigational drug will be measured to compare with and without the co-administration of other drugs [ Time Frame: 72 hours post-dose ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mds Pharma Services (Us) Inc. | Neptune City | New Jersey | 07753 | - |
Find similar trials in Neptune City, NJ
By condition
By specialty
By research site
Related Studies
- An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsRecruiting · Bayer · Multiple Locations, New Jersey
- Continued Access to the Endogenex System for Participants in the ReCET Pivotal StudyEnrolling By Invitation · Endogenex, Inc. · Birmingham, Alabama
- Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)Recruiting · Petter Bjornstad · Aurora, Colorado
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePHASE3 · Recruiting · Prokidney · Huntsville, Alabama